Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Stimcell Energetics (STME) Risk Analysis

Public companies are required to disclose risks that can affect the business and impact the stock. These disclosures are known as “Risk Factors”. Companies disclose these risks in their yearly (Form 10-K), quarterly earnings (Form 10-Q), or “foreign private issuer” reports (Form 20-F). Risk factors show the challenges a company faces. Investors can consider the worst-case scenarios before making an investment. TipRanks’ Risk Analysis categorizes risks based on proprietary classification algorithms and machine learning. Stimcell Energetics disclosed 22 risk factors in its most recent earnings report. Stimcell Energetics reported the most risks in the “Finance & Corporate” category.

Risk Overview Q2, 2026

Source: the company's latest filing for the period ended May 31, 2026, filed Aug 31, 2026

Risk Distribution
22Risks
Sector Avg.Finance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Risk Change Over Time

Stimcell Energetics disclosed risks per quarterNo. of Risks181920212223Q3Q4Q12023Q2Q3Q4Q12024Q2Q3Q4Q12025Q2Q12026Q2Showing: Q2, 2026
Risks removedRisks addedRisks changedStimcell Energetics Risk Factors
  • Debt & Financing - Risk 1
    Debt Owing to Related Parties

    As of May 31, 2026, the Company had approximately $1,498,798 in amounts due to related parties and notes payable, consisting of amounts due to related parties of $665,321 and notes and advances payable of $833,477. If the Company is unable to repay these amounts when due, it may be required to settle the debt through the issuance of Common Shares, which would result in dilution to existing shareholders. The Company has previously settled related party debt through the issuance of Common Shares, including the conversion of $1,622,693 in outstanding debt into 15,454,221 Common Shares in December 2023.

Read and Evaluate the RiskReserved for Ultimate MembersUpgrade
Production (1)
Macro & Political (1)

Risk Highlights Q2, 2026

Main Risk Category
Finance & Corporate
With 10 Risks
Number of Disclosed Risks
22
+3
From last report
S&P 500 Average: 32
Recent Changes
3Risks added
0Risks removed
0Risks changed
Since May 2026
Number of Risk Changed
0
No changes from last report
S&P 500 Average: 1

Risk Word Cloud

should a larger public market develop for the company's stock, future sales of shares may negatively affect their market price.larger public market developchanges in the health care regulatory environment may adversely affect the company's business.health care regulatory environmentthe company has not paid nor anticipates paying cash dividends on its common stock.anticipates paying cash dividendseven if the company successfully develops marketable products or commercially develop its current technology, it may be quickly rendered obsolete by changing customer preferences, changing industry standards, or competitors' innovations.company successfully develops marketable productsdebt owing to related partiesdebt owing to related partiesthe company is subject to numerous governmental regulations which can increase its costs of developing the ebalance technology and products based on this technology.subject to numerous governmental regulationsthe company lacks operating history and to date has generated only minimal revenues. if the company cannot increase its revenue to start generating profits, its investors may lose their entire investment.revenue to start generating profitsthe company operates in a highly competitive market. the company faces competition from large, well established medical device manufacturers and pharmaceutical companies in the market for treatment of pain and management of diabetes and related ailments. many of these companies are very well accepted by health practitioners and have significant resources, and the company may not be able to compete effectively.established medical device manufacturersthe company needs to acquire additional financing, or its business will fail.to acquire additional financingthe company lacks operating history and to date has generated only minimal revenues. if the company cannot increase its revenue to start generating profits, its investors may lose their entire investment.company lacks operating history

Risk Factors Full Breakdown - Total Risks 22

Share Price & Shareholder Rights5 | 22.7%
  • Share Price & Shareholder Rights - Risk 1
    The Company expects to raise additional capital through the offering of more shares, which will result in dilution to its current shareholders.

    Raising additional capital through future offerings of common stock is expected to be necessary for the Company to continue. However, there is no guarantee that the Company will be successful in raising additional capital. Issuance of additional stock will increase the total number of shares issued and outstanding resulting in decrease of the percentage interest held by each of the Company's shareholders.

  • Share Price & Shareholder Rights - Risk 2
    The Company may, from time to time, convert some of its debt into shares of the Company's common stock, which will result in dilution to its shareholders.

    To reduce the Company's liabilities and improve its financial position, the Company may convert its debt into shares of common stock. The issuance of additional stock increases the total number of shares issued and outstanding, resulting in a decrease in the percentage of interest held by each of the Company's shareholders, thereby further diluting their position.

  • Share Price & Shareholder Rights - Risk 3
    There is a limited market for the Company's common stock, meaning that its shareholders may not be able to resell their shares.

    The Company's common stock currently has a limited market, which may restrict shareholders' ability to resell their stock or use their stock as collateral. Thus, the shareholders may have to sell their shares privately, which may prove exceedingly difficult. Private sales are more difficult and often give lower-than-anticipated prices.

  • Share Price & Shareholder Rights - Risk 4
    Should a larger public market develop for the Company's stock, future sales of shares may negatively affect their market price.

    Even if a larger market develops, the shares may be sparsely traded and have wide share price fluctuations. Liquidity may be low despite there being a market, making it difficult to get a return on the investment. The price also depends on potential investors' feelings regarding the results of the Company's operations, the competition of other companies' shares, its ability to generate future revenues, and market perception about the future of microcurrent technologies.

  • Share Price & Shareholder Rights - Risk 5
    Because the Company's stock is a penny stock, stockholders will be more limited in their ability to sell their stock.

    The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or quoted on the NASDAQ system, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or quotation system. Because the Company's securities constitute "penny stocks" within the meaning of the rules, the rules apply to the Company and to its securities. The rules may further affect the ability of owners of shares to sell the Company's securities in any market that might develop for them. As long as the quotation price of the Company's common stock is less than $5.00 per share, the common stock will be subject to Rule 15g-9 under the Exchange Act. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock, to deliver a standardized risk disclosure document prepared by the SEC, that: - contains a description of the nature and level of risk in the market for penny stocks in both public offerings and secondary trading;- contains a description of the broker's or dealer's duties to the customer and of the rights and remedies available to the customer with respect to a violation to such duties or other requirements of securities laws;- contains a brief, clear, narrative description of a dealer market, including bid and ask prices for penny stocks and the significance of the spread between the bid and ask price;- contains a toll-free telephone number for inquiries on disciplinary actions;- defines significant terms in the disclosure document or in the conduct of trading in penny stocks; and - contains such other information and is in such form, including language, type, size, and format, as the SEC shall require by rule or regulation. The broker-dealer also must provide, prior to effecting any transaction in a penny stock, the customer with: (a) bid and offer quotations for the penny stock; (b) the compensation of the broker-dealer and its salesperson in the transaction; (c) the number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the market for such stock; and (d) a monthly account statements showing the market value of each penny stock held in the customer's account. In addition, the penny stock rules require that, prior to a transaction in a penny stock not otherwise exempt from those rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser's written acknowledgment of the receipt of a risk disclosure statement, a written agreement to transactions involving penny stocks, and a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for the Company's stock.

Accounting & Financial Operations3 | 13.6%
Debt & Financing2 | 9.1%

See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.

FAQ

What are “Risk Factors”?
Risk factors are any situations or occurrences that could make investing in a company risky. The Securities and Exchange Commission (SEC) requires that publicly traded companies disclose their most significant risk factors. This is so that potential investors can consider any risks before they make an investment. They also offer companies protection, as a company can use risk factors as liability protection. This could happen if a company underperforms and investors take legal action as a result. It is worth noting that smaller companies, that is those with a public float of under $75 million on the last business day, do not have to include risk factors in their 10-K and 10-Q forms, although some may choose to do so.
How do companies disclose their risk factors?
Publicly traded companies initially disclose their risk factors to the SEC through their S-1 filings as part of the IPO process. Additionally, companies must provide a complete list of risk factors in their Annual Reports (Form 10-K) or (Form 20-F) for “foreign private issuers”. Quarterly Reports also include a section on risk factors (Form 10-Q) where companies are only required to update any changes since the previous report. According to the SEC, risk factors should be reported concisely, logically and in “plain English” so investors can understand them.
How can I use TipRanks risk factors in my stock research?
Use the Risk Factors tab to get data about the risk factors of any company in which you are considering investing. You can easily see the most significant risks a company is facing. Additionally, you can find out which risk factors a company has added, removed or adjusted since its previous disclosure. You can also see how a company’s risk factors compare to others in its sector. Without reading company reports or participating in conference calls, you would most likely not have access to this sort of information, which is usually not included in press releases or other public announcements. A simplified analysis of risk factors is unique to TipRanks.
What are all the risk factor categories?
TipRanks has identified 6 major categories of risk factors and a number of subcategories for each. You can see how these categories are broken down in the list below. 1. Financial & Corporate Accounting & Financial Operations - risks related to accounting loss, value of intangible assets, financial statements, value of intangible assets, financial reporting, estimates, guidance, company profitability, dividends, fluctuating results. Share Price & Shareholder Rights – risks related to things that impact share prices and the rights of shareholders, including analyst ratings, major shareholder activity, trade volatility, liquidity of shares, anti-takeover provisions, international listing, dual listing. Debt & Financing – risks related to debt, funding, financing and interest rates, financial investments. Corporate Activity and Growth – risks related to restructuring, M&As, joint ventures, execution of corporate strategy, strategic alliances. 2. Legal & Regulatory Litigation and Legal Liabilities – risks related to litigation/ lawsuits against the company. Regulation – risks related to compliance, GDPR, and new legislation. Environmental / Social – risks related to environmental regulation and to data privacy. Taxation & Government Incentives – risks related to taxation and changes in government incentives. 3. Production Costs – risks related to costs of production including commodity prices, future contracts, inventory. Supply Chain – risks related to the company’s suppliers. Manufacturing – risks related to the company’s manufacturing process including product quality and product recalls. Human Capital – risks related to recruitment, training and retention of key employees, employee relationships & unions labor disputes, pension, and post retirement benefits, medical, health and welfare benefits, employee misconduct, employee litigation. 4. Technology & Innovation Innovation / R&D – risks related to innovation and new product development. Technology – risks related to the company’s reliance on technology. Cyber Security – risks related to securing the company’s digital assets and from cyber attacks. Trade Secrets & Patents – risks related to the company’s ability to protect its intellectual property and to infringement claims against the company as well as piracy and unlicensed copying. 5. Ability to Sell Demand – risks related to the demand of the company’s goods and services including seasonality, reliance on key customers. Competition – risks related to the company’s competition including substitutes. Sales & Marketing – risks related to sales, marketing, and distribution channels, pricing, and market penetration. Brand & Reputation – risks related to the company’s brand and reputation. 6. Macro & Political Economy & Political Environment – risks related to changes in economic and political conditions. Natural and Human Disruptions – risks related to catastrophes, floods, storms, terror, earthquakes, coronavirus pandemic/COVID-19. International Operations – risks related to the global nature of the company. Capital Markets – risks related to exchange rates and trade, cryptocurrency.